Analysts Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Target Price at $4.00

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has received a consensus recommendation of “Hold” from the five research firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $4.00.

Several equities analysts recently issued reports on the company. Canaccord Genuity Group decreased their price objective on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating for the company in a research report on Friday, January 2nd. Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research note on Monday, December 29th. Wall Street Zen raised shares of Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a research report on Saturday, November 22nd. Finally, Oppenheimer cut Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a research note on Wednesday, October 22nd.

Bioceres Crop Solutions Stock Up 2.5%

Shares of BIOX opened at $1.22 on Friday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.64 and a current ratio of 0.94. Bioceres Crop Solutions has a 52 week low of $1.17 and a 52 week high of $7.44. The firm has a market capitalization of $77.14 million, a price-to-earnings ratio of -1.45 and a beta of 0.47. The business’s fifty day moving average price is $1.51 and its two-hundred day moving average price is $2.28.

Institutional Investors Weigh In On Bioceres Crop Solutions

A number of large investors have recently modified their holdings of BIOX. Ardsley Advisory Partners LP raised its stake in Bioceres Crop Solutions by 4.7% during the second quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company’s stock valued at $4,441,000 after buying an additional 45,000 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Bioceres Crop Solutions by 9.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company’s stock valued at $3,761,000 after buying an additional 71,581 shares during the period. Ballast Asset Management LP increased its holdings in Bioceres Crop Solutions by 69.9% during the third quarter. Ballast Asset Management LP now owns 745,030 shares of the company’s stock valued at $1,048,000 after buying an additional 306,624 shares during the last quarter. Susquehanna International Group LLP bought a new position in Bioceres Crop Solutions in the third quarter worth approximately $315,000. Finally, Tudor Investment Corp ET AL boosted its stake in shares of Bioceres Crop Solutions by 119.4% during the 3rd quarter. Tudor Investment Corp ET AL now owns 220,500 shares of the company’s stock worth $311,000 after acquiring an additional 120,000 shares during the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.